Throughout Tuesday’s buying and selling session, the shares of an organization engaged in manufacturing sugar, industrial alcohol, chlor alkali merchandise, aspirin, sulphuric acid, and liquid & strong propellants surged practically 3.2 % on NSE, after the promoter elevated acquired shares value Rs. 1.35 lakhs within the firm.
Worth Motion
With a market cap of Rs. 489.2 crores, the shares of The Andhra Sugars Restricted closed within the inexperienced at Rs. 68.85, up by 2.5 % on NSE, as in comparison with its earlier closing value of Rs. 67.17.
What’s the Information
In accordance with the newest filings with the NSE, Pendyala Achuta Ramayya, the Joint Managing Director and Member of Promoter group, has bought an extra 2,000 fairness shares value Rs. 1.35 lakhs on NSE, growing his stake from 0.755 % to 0.757 %.
Earlier Information
eleventh February: The corporate’s Board authorized the organising of a 6 TPD Sodium Sulphate Restoration Plant with an estimated funding of Rs. 12 crore, together with a 12 MW solar energy challenge with a capital outlay of Rs. 42 crore to fulfill the captive energy wants of its present caustic soda plant. Additionally learn: Metallic inventory jumps 4% after buying 51% stake in Surana Electrix for photo voltaic vitality associated merchandise
Monetary Efficiency
Andhra Sugars skilled vital development in its income from operations, displaying a year-on-year rise of round 13.3 % from Rs. 451 crores in Q3 FY24 to Rs. 511 crores in Q3 FY25. In distinction, throughout the identical interval it turned from a internet revenue of Rs. 8.6 crores to a lack of Rs. 0.42 crores.
In regards to the Firm
Established in 1947, The Andhra Sugars Restricted is engaged within the enterprise of producing sugar, industrial alcohol, & chlor alkali merchandise, aspirin, sulphuric acid, liquid & strong propellants, and likewise producing energy via renewable and non-renewable assets. The corporate is primarily engaged in three segments: Sugars, Chemical compounds & Fertilizers, and Pharma.
Written by Shivani Singh
Disclaimer
The views and funding suggestions expressed by funding consultants/broking homes/ranking businesses on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a danger of economic losses. Traders should due to this fact train due warning whereas investing or buying and selling in shares. Dailyraven Applied sciences or the writer are usually not chargeable for any losses induced because of the choice primarily based on this text. Please seek the advice of your funding advisor earlier than investing.
